FDA's meeting of Antiviral Drugs Advisory Committee.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015195:Drug Design; D015658:HIV Infections / Q000150:complications; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents